Article Text
Commentary
Moving forward with the detection of chronic liver disease
Statistics from Altmetric.com
Footnotes
Twitter @stumcp
Contributors Commentary jointly written by JS and SM.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests SM is chair of the BASL/BSG NAFLD Special Interest Group and was co-lead of the UK National Audit on NAFLD. He is also chief investigator of the SOLID study, which is evaluating the use of non-invasive fibrosis biomarkers at the primary-secondary care interface. JS has no conflict of interest.
Provenance and peer review Not commissioned; internally peer reviewed.